About Asprant
Asprant is a Healthcare company. Pharmaceutical medicines and services in India. The company has 10 employees. Its Indian entity Asprant Life Science Private Limited reported revenue of βΉ1.16 Cr. Asprant offers products and services including Afelon Medicine and Asphen-650 Medicine. Its focus areas include Life Sciences, Biotech Products, Syrups and Tablets and Pharmaceuticals.
Company details
Asprant Life Science Private Limited is recognized as a private company that was incorporated on 24 May 2018 in Kolkata, West Bengal. It is classified as a key entity in the pharmaceutical sector, where various medicines such as Afelon and Asphen-650 are offered. The company is managed by directors including Sutapa Chakraborty and is governed by principles of innovation and integrity. Its mission emphasizes the provision of high-quality products that contribute positively to communities and stakeholders, with a commitment to sustainability and ethical practices. Operations are supported by regional offices in Guwahati and Cuttack, ensuring wider reach.
- Employees 10
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website asprant.com
- Legal Name Asprant Life Science Private Limited
- Date of Incorporation 24 May, 2018
- Jurisdiction Kolkata, West Bengal, India
- Indian entity revenue₹1.16 Cr
FY 2025 · -10% YoY
- Indian entity net loss-₹3,840
FY 2025 · 0% margin
- Indian entity EBITDA₹3.1 Lakh
FY 2025 · 3% margin
- Employee Count10
Associated legal entities of Asprant
Asprant operates through Asprant Life Science Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Asprant Life Science Private Limited CIN U24299WB2018PTC226270 | Active | 24 May 2018 | Kolkata, West Bengal | ₹1.2 Cr | 10 | 4 | View details |
Products & Services of Asprant
Asprant offers a comprehensive portfolio of products and services, including Afelon Medicine and Asphen-650 Medicine.
Afelon Medicine is offered as a pharmaceutical product for health applications.
Asphen-650 Medicine is provided as a medicinal solution for specific health needs.
Board of directors of Asprant Life Science Private Limited (Asprant)
Asprant Life Science Private Limited is the primary company behind Asprant. The board of Asprant Life Science Private Limited currently have 4 directors; the longest-serving is Sutapa Chakraborty, appointed in 2018. 6 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sutapa Chakraborty DIN 08292937 | Director | 01 Dec 2018 | 7 yrs 11 mo | Asprant Life Science Private Limited |
| Santanu Chakraborty DIN 09488796 | Director | 01 Feb 2022 | 4 yrs 9 mo | Asprant Life Science Private Limited |
| Raju Talukdar DIN 09826681 | Director | 15 Dec 2022 | 3 yrs 11 mo | Asprant Life Science Private Limited |
| Suvam Chakraborty DIN 09826612 | Additional Director | 29 Nov 2024 | 1 yr 11 mo | Asprant Life Science Private Limited |
Financials of Asprant
Figures of Asprant Life Science Private Limited, the primary company behind Asprant, for FY 2025. Revenue was ₹1.16 Cr (-10% year on year). Net loss was -₹3,840 (0% margin). EBITDA was ₹3.1 Lakh (3% margin). Revenue has grown at a compounded annual rate of -7% over three years and -11% over five years.
- ₹1.16 CrRevenue · FY 2025 · -10% YoY
- -₹3,840Net loss · 0% margin
- ₹3.1 LakhEBITDA · 3% margin
- ₹1.6 LakhPaid-up capital
- 10Employees (provident fund records)
- -7%Revenue CAGR, 3 years
- -11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Asprant Life Science Private Limited are on its company page.
Detailed financial statements for Asprant
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Asprant
Asprant has 10 employees.
The primary company behind Asprant, Asprant Life Science Private Limited, reported revenue of βΉ1.16 Cr for FY 2025, down 10% year on year.
Asprant Life Science Private Limited is recognized as a private company that was incorporated on 24 May 2018 in Kolkata, West Bengal. It is classified as a key entity in the pharmaceutical sector, where various medicines such as Afelon and Asphen-650 are offered. The company is managed by directors including Sutapa Chakraborty and is governed by principles of innovation and integrity. Its mission emphasizes the provision of high-quality products that contribute positively to communities and stakeholders, with a commitment to sustainability and ethical practices. Operations are supported by regional offices in Guwahati and Cuttack, ensuring wider reach.
Asprant offers Afelon Medicine and Asphen-650 Medicine.
Asprant operates through Asprant Life Science Private Limited.
The legal entities of Asprant currently have 4 directors, including Sutapa Chakraborty, Raju Talukdar, Suvam Chakraborty and others.
